Luis Roa W

Clinical Characterization and Predictors of Poor Outcome in Patients with Cerebral Venous Thrombosis: Experience from a Latin American Cohort - Journal of Stroke and Cerebrovascular Diseases strokejournal.org/article/S1052-…

Case-fatality of acute ischemic stroke in stroke units of Latin Americ... sciencedirect.com/science/articl…

#WSC2025 Late breaking trials #TRIDENT Intensive BP control w/ a single ‘triple pill’: telmisartan 20mg+amlodipine 2.5mg+indapamide 1.25mg, for 2ry prevention after ICH 1670pts, ~58y, 33%female 1ry outcome, recurrent stroke: HR 0.61 p=0.017 NNT 27 👏👏 @georgeinstitute

La Máquina de Maripolles de Wintergatan es un instrumento hecho a mano por el músico sueco Martin Molin, que utiliza 2000 bolitas de mármol para interpretar una melodía única.

Vea este proyecto en Universidad del Rosario: Caracterización de pacientes con encefalopatía posterior reversible (PRES) en dos instituciones en Bogotá, Colombia entre 2017 y 2023 pure.urosario.edu.co/es/projects/ch…

#Mondaytip ☝️After #ICH, patients aren't only at risk of recurrence but also IS👉especially w/AF After COCROACH metaanalysis, PRESTIGE-AF is the 1st large RCT to provide new data ⚖️Stroke prevention and bleeding risk remains critical Awaiting results from at least 2+ ongoing RCTs

🎓New #IschemicStroke e-Learning module available! world-stroke-academy.org/courses/wso-ws… 👉Stroke care: from pre-hospital management to advanced treatment strategies Duration: 5 hours ✍ Complete the quiz and get your certificate of completion! #StrokeEducation #MedicalLearning

The @US_FDA has approved #TNKase (#Tenecteplase; @genentech) for the treatment of adults with acute #ischemic #stroke. TNKase was found to be noninferior to #Activase, and in safety analysis, TNKase and Activase demonstrated comparable rates of 24-hour symptomatic intracerebral hemorrhage and death. practicalneurology.com/news/fda-appro… @EVToday @American_Heart @American_Stroke

#MondayTip Key studies on #DOAC vs VKA in CVT 🧠Several observational studies and small but important RCTs have evaluated the efficacy and safety of DOACs as an alternative to VKAs in Cerebral Venous Thrombosis ✅Results support DOACs as a reasonable treatment option

Check out our new scientific statement about ischemic stroke prevention in patients with AFib and recent ischemic stroke, TIA or ICH #stroke #neurocriticalcare #neurology #MedEd @SposatoL

Similar to CRASH trials, 1) INTERACT 1 - Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage (Pilot Phase study) 2) INTERACT 2 - Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage (Main Phase study) 3) INTERACT 3 - Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial In INTERACT 1&2 - SBP less than 140 mm Hg was targeted within 1 hour. In INTERACT 3 - Along with SBP target < 140 mm Hg, a bundled approach with rapid reversal of warfarin related anticoagulation, strict glucose and temperature control was tested. All these trials led to the development of CODE ICH with a goal of reducing mortality and morbidity of patients suffering from ICH. doi.org/10.1007/s00134…

GSA/SIECV 2024 @SIECV_IASO @ALATACV @lumniwomanlatam @AlianzaAcvCol @ACNeurologia

Acompáñanos al taller de neurosonologia en el GSA/SIECV 2024 @SIECV_IASO @ALATACV @AlianzaAcvCol @ACNeurologia

Day 3 Clinical Trials #WSC2024 @WorldStrokeOrg Intra-arterial TNK not helpful in posterior circulation stroke, more evidence for minimally invasive surgery for ICH, MRI was non-inferior to CTP based patient selection for EVT and DOACs safe but not efficacious in CVT #strokemed

Day 2 Clinical Trials: Step towards non-gated single-phase cardiac-neck-brain CTA, OPTIMAS/CATALYST will change guidelines, early anticoagulation can be implemented more convincingly, BP reduction <130 is better for overall CVD reduction #WSC2024 @WorldStrokeOrg #stroke

Day 1 Clinical trial #WSC2024 Balloon Guide catheter trial stopped earlier and primary stroke prevention trial #stroke @WorldStrokeOrg

🔥 CATALYST 🔥 👉🏻individual patient data meta analysis 👉🏻DOAC resumption after AIS 👉🏻early <4d vs late >=5d 👉🏻early 💊<1 outcome < AIS without >sICH #WSC2024 @DavidSeiffge @interneurona @ShadiYaghi2 @WorlStrokeOrg @SposatoL

Starting DOAC within 4 days after stroke is NOT inferior to delayed initiation after 7 days. OPTIMAS trial published in Lancet this morning #WSC2024

Mimics of medium or large vessel #vasculitis. *Seitz, L., Seitz, P., Pop, R. et al. Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases. Curr Rheumatol Rep 24, 352–370 (2022). 🔗doi.org/10.1007/s11926…

schematic of arterial supply of the Internal Capsule DOI:10.1016/j.cnp.2022.07.001 #stroke #neurotwitter #strokemed